What You Should Know:
- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
- This investment will support Ritten's expansion across mental health and addiction treatment providers spanning all levels of care.
A Unified Platform Purpose-Built for Behavioral Health
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Moving Beyond the Worklist: Agentic AI and Radiology’s Next Efficiency Leap
After years of flat or falling payment rates, radiology providers are being asked to do more with less. Medicare cuts continue to squeeze margins, and inflation-driven cost hikes in labor and supplies further strain budgets. At the same time, workforce shortages have left many radiology departments shorthanded and clinicians overextended. Meanwhile, the traditional follow-up worklist-centric model—essentially a growing to-do list of patients needing outreach, navigation, and scheduling—is
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
Beyond Wearables: How Radar Technology is Revolutionizing Elderly Sleep Monitoring
Radar holds the potential to change the way we look after elderly people, with new radar-based sleep monitors offering a way to rethink the way elderly people are monitored both in elder care facilities and in their own homes. Traditional monitoring techniques have significant drawbacks when it comes to elder care: for example, cameras have significant privacy, security and compliance concerns, and wearables have practical issues both in elder care facilities and the home.
By
Read More
Mount Sinai’s AI Tool “V2P” Predicts Disease Type from Genetic Mutations
What You Should Know:
- Scientists at the Icahn School of Medicine at Mount Sinai have developed a new artificial intelligence tool called V2P (Variant to Phenotype) that identifies not only disease-causing genetic mutations but also predicts the specific diseases they may trigger.
- Published in Nature Communications, this machine learning model improves diagnostic speed and accuracy by linking genetic variants to phenotypic outcomes, moving beyond simple "harmful vs. benign"
Read More
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know:
- Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root.
- Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform.
- Priced at $149 per month, the program aims to shift the healthcare paradigm
Read More
PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage
What You Should Know:
- The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications.
- The report recommends a shift away from broad, unchecked coverage toward a managed approach focused on three phases: Initiation (strict eligibility), Maintenance (adherence support), and Supported Discontinuation (managing off-ramps).
- PHTI urges employers to demand
Read More
The AI Paradox: Why Some Tools Save Millions While Others Increase Physician Burnout
AI has become everyone’s favourite topic in healthcare. From predicting diseases to creating personalised treatment plans, it’s already changing how hospitals, insurers, and health tech companies work. But behind all the excitement sits one big question: is AI really paying off, or is it just more talk than truth?
Like any other business, healthcare organisations need to see clear financial results before calling AI a success. The real question isn’t just how advanced the technology
Read More
Lunit and Daiichi Sankyo Partner to Accelerate Cancer Biomarker Discovery with AI
What You Should Know:
- Lunit has announced a collaboration with pharmaceutical giant Daiichi Sankyo to integrate its AI-powered Lunit SCOPE digital pathology products into two of Daiichi Sankyo's oncology pipeline programs.
- The partnership will utilize Lunit's SCOPE uIHC and SCOPE IO solutions to analyze pathology slides for quantitative data and immune phenotyping, aiming to discover novel biomarkers and improve patient stratification for clinical trials. This move underscores
Read More
